Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Dundee Corp T.DC.A

Alternate Symbol(s):  T.DC.P.B | T.DC.P.D | DNDEF | DNDPF | DDEJF

Healthcare Metals & Mining Technology Gold Silver
Dundee Corporation is a Canada-based holding company. Through its operating segments, the Company is a mining- focused investor primarily engaged in acquiring mineral resource assets. Its segments include Corporate and Other Portfolio Holdings; Goodman & Company, Investment Counsel Inc.; Dundee Sustainable Technologies Inc.; United Hydrocarbon International Corp., and Dundee 360 Real Estate... see more

TSX:DC.A - Post Discussion

Dundee Corp > TaurX
View:
Post by valueinvestor89 on May 26, 2022 2:15pm

TaurX

https://www.prnewswire.com/in/news-releases/taurx-s-late-stage-clinical-trial-reaches-new-milestone-893482727.htmltaurx press release here

We should expect some big news in the next few days with regards to the phase 3 trials of TaurX (alzheimer's cure/delay). The carrying value is $35m and it owns about 4% of the company. 

The top line results of the trial come out at the end of may which will give us a good idea if the investment is worth $400m or 0 at our share. in 2016 the thought were that Taurx will IPO at $15bn USD so the $400m i made up for illustrative purposes is based on an $8bn valuation or half of the original expectations.

Worth adding units in my opinion now as i've always internally carried TaurX as 0 and can participate in the upside if the results are positive.
Comment by Catscratch on May 26, 2022 7:37pm
DC.A's share price is reflecting no value for Taurx so I think it's a heads you win / tails your don't lose, situation. Fingers crossed for some positive results but not holding my breath.
Dundee Corp
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities